
Meta-pin👇

AI and Rare Disease. Current: Life Science @AnthropicAI and Clinical Genetics @seattlechildren Past: @OpenEvidence, MD-PhD @harvardmed / @MIT_CSAIL, @Stanford

Meta-pin👇

The first @GamowLabs peer-reviewed scientific publication just appeared in the American Journal of Medical Genetics Part A. We show that we can use George, our clinical genomics agent, to identify two lethal balanced translocations in previously unsolved alveolar capillary dysplasia cases. These diagnoses went undetected by traditional NGS methods and would have been invisible to older techniques like karyotyping due to their position. I hope that this is the first of many and we can continue to contribute to advances in the field. onlinelibrary.wiley.com/doi/…

Career update/news including that I'm hiring! Late in the summer, I made the jump to @AnthropicAI to help co-lead a moonshot effort in genetic medicine. I'm hoping to have a proper update to share publicly fairly soon, but if you know my collection of interests (AI, clinical genetics, therapeutics, rare disease non-profits), you are unlikely to be surprised. Much of the upfront effort here requires infra for moving atoms as well as bits, and we explicitly want to lean deeply into collaborations with academics, non-profits, and key industry partners in the space. If either of the below roles sound like you, please apply through the link. More to come! Program Manager: job-boards.greenhouse.io/ant… CMC and Manufacturing Lead: job-boards.greenhouse.io/ant…

Classic machine learning is BACK, BABY
Introducing e-means, an algorithm beating k-means in 10x fewer epochs. With order of magnitude wall-clock speedups, e-means is released in FAISS and needs no hyperparameter tuning beyond k. It is robust to various scales and datasets. Still skeptical ? Just try e-means [1/10]🧵

Every single early-stage biotech investor and biotech researcher should read the linked paper on reading a mouse study. Cage effects, early deaths, broken axes, n-hacking with small effect sizes, artifacts from fluid retention delaying weight-linked termination, "Something that works 20% actually doesn’t work at all.” cureffi.org/2026/11/03/how-t…
How many times have you seen a mouse study claiming that a therapeutic works, and the survival curve looks like this? Broken axis, 6% difference in survival time, but the P value is < 0.05 and it's claimed as a positive result. It's not. In my 15 years of prion science, I have learned to look past such claims almost instantly. Yet sometimes these claims still lead to high-profile publications, millions of dollars in funding, and even to therapies being tested clinically. In this new blog post I release data on 301 untreated control animals from our last 9 years of in vivo studies, model out the various ways that P values can appear significant even when the result is null, and put into words the intuition I've built up as to which claims are believable and which are not. cureffi.org/2026/11/03/how-t…

Thrilled to share new work from our experimental biology lab at @AnthropicAI. Led by world-class biochemist Januka Athukoralage, we built a rapid method for the isolation and structural characterization of vaults. It turns out these massive structures are not just found in eukaryotic cells, but also in prokaryotes and even phages. We solve the structure of one of these phage vaults, and then demonstrate we can engineer additional repeats into the wall to make it bigger. One thing I can't get over about these vaults. They seem to be widespread across life - we assembled them from 8 different bacteria and bacteriophages. But they are just so massive - bigger than ribosomes, AAV, and even some phage capsids. Why devote so much energy to making these huge complexes? They have to be doing something useful - I hope that's the question that gets answered next. Amazing collaboration with @PeterHYoon, @amirshanehsaz, @eric_kabrams, and @mgdurrant! Grateful to our team for making Claude an amazing labmate and to Anthropic for supporting this type of work on fundamental biology. Natural mysteries abound - let's get to solving them! Links here: Blog: anthropic.com/research/inves… Technical report: www-cdn.anthropic.com/76e55f…

Labor of love here, more than a year in the making 👇
🚨Introducing the SAIL Therapeutic Actionability AI Challenge🚨 ~450M people have a rare disease, often facing decades-long journeys to find therapies. <10% of rare diseases have an FDA-approved one. We think AI can help close this gap. Submit your model by Jan 5. Details 👇

Variant effect predictors are shaping the ClinVar classifications used to train and evaluate them biorxiv.org/content/10.64898…

I believe that the best way to accelerate curing disease is to run lots of real drug programs with Claude, across disease areas and stages of development, and get a little better at it every day. The bottlenecks are everywhere, not just in the initial stages of molecule design that tend to dominate the public discourse. Today we're sharing early results from six research partnerships, using Claude in things like CAR-T design, lead optimization for antibodies, drafting of regulatory documents, and partnering with a new biotech company built to run many more programs than a small team usually can. We're also sharing results for the first time from our own drug programs in rare childhood disease. Our approach to drug development owes a lot to @Prof_Oak_ . His "pipeline-in-a-person" vision was the first take on how to use AI in drug development that I found to be simultaneously AI-pilled and rigorously grounded in cold, hard reality. Welcome to Anthropic, Cody!
Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own. In doing so, we’ve learned much more about how Claude can support the many stages of drug development. In this blog post, we share some early results from these efforts, and describe how this work fits in with our wider ambitions in the life sciences. anthropic.com/research/early…

Excited to share full data for BEAM-301 in GSD1a, covering the first two dose cohorts ** Importantly, 2/3 patients at the 2nd dose level achieved maximum fasting duration and no longer require corn starch supplementation after a single dose of BEAM-301 globenewswire.com/news-relea…

Saline: a cheap and easy treatment for the common cold. In this trial, hypertonic saline nasal rinsing + gargling: 1) shortened illness by 1.9 days 2) reduced OTC medication use by 36%, and was 3) linked to 35% fewer reported household infections

what our Chief Scientist builds on the side is astonishing.
To show what that looks like for imaging, I spent <24h designing a small protocol extension to make SMART Health Links stream massive DICOM studies and building an end-to-end demo.


I’ve long felt that @OpenEvidence query data is the medical equivalent of the Google street view cameras, providing a first-hand look at how clinicians navigate the terrain of clinical knowledge, both knowns and unknowns. IMO there is so much utility in using these data to discover trends in our practice, holes in our guidelines, emerging clinical needs, opportunities for impact. But obviously, any mining of these data has to be approached with great care, for patient safety and clinician trust. This paper is a first measured step in publishing trends from OE data (other than implicitly through work with, eg society guidelines). It focuses on basic trends in who is using the platform and for what purpose. Excited to see it out. So much fun working with @TravisZack2 and our colleagues from Harvard on this. Other efforts are in the works and I hope there is much more to come in the genre of @OpenEvidence -> new evidence.
In @JAMA_current led by @vrpatel97, @IAmSamFin and @AnupamBJena: how are US 👨⚕️ actually using AI? We analyzed 271M queries from 950K+ clinicians on @OpenEvidence over 2.5 years. Monthly active users grew from 355 to 700K+, and 9/10 kept coming back. Link: jamanetwork.com/journals/jam…

Pediatricians submitting our wellness surveys next to our friends from NSGY and Derm
Physician compensation versus lifestyle balance (a composite index by Marit that accounts for weekly hours, long shift or after-hours work, call burden, and vacation weeks) by major specialty

Welcome To the era of Super intelligence : Fable 5.5 behold superman in continuous animation in different art style
🚨 Fable 5.5 is auto routing on web , this is the screenshot it edited for x without even prompted he knows tibo check claude.ai see if you are getting routed or not

This is a huge deal, and a great time to remember that when people and organizations make a pivot on an issue that has historically been an in-group/out-group identify marker, it can be a very destabilizing experience. Even — and especially — if you felt their old position was stupid, it’s important to meet that vulnerability with compassion rather than derision.
Jehovah’s Witnesses can now receive blood transfusions. USMLE question writers in full scale panic. abc.net.au/news/2026-09-24/j…